Tampa Bay woman with Hepatitis C reduces co-pay for treatments with coupon

PASADENA, FL (WFLA) — The FDA has approved several new cures for people fighting chronic diseases, but the problem is, many people can’t afford the drugs and insurance companies will cover only the sickest patients. That includes a drug now on the market for people with Hepatitis C called Harvoni — a pill that patients take for 8 to 12 weeks. Wendy Latorre, of Pasadena, says when she heard about the drugs she was extremely hopeful. “And then I found ou

U.S.: Denying Medicaid Patients Access to Hep C Treatments is Wrong and Illegal

Elizabeth G. Taylor Executive Director of the National Health Law Program (NHeLP) Imagine you are diagnosed with cancer. Your doctor tells you that your cancer is completely curable. But unfortunately, the cure is very expensive. It is so expensive that your insurance won’t pay for the cure until your cancer has advanced to stage three. You will have to suffer for months — possibly even years — before you have a chance at a cure. You may experience

What price a miracle? Limited access to hepatitis-C drug sparks debate

WASHINGTON – Jose Robles is the picture of health. And because of that, he has to remain sick, even though new drugs would likely cure him of the disease he’s had since birth. Robles, born with hepatitis C, is currently asymptomatic, but when he tried to enlist in the Marines, they turned him down because his ailment made him a “liability.” Determined to make good on a promise to his honorably discharged brother, Robles spoke with his doctor who quickly...

U.S: Good Days Announces New Alliance with Help-4-Hep to Provide Holistic Support for People with Hepatitis C

PLANO, Texas--(BUSINESS WIRE)--Good Days, a national non-profit providing financial assistance to patients with chronic disease, cancer, and other life-altering illness, announced its partnership with Help-4-Hep, a non-profit providing peer-to-peer counseling to patients affected with hepatitis C, in the effort to offer a complete approach to serving patients.Hepatitis C is a silent and potentially deadly chronic liver disease. According to the Centers for

U.S.: NY attorney general to investigate insurers over hepatitis C drugs

New York state Attorney General Eric Schneiderman's office has asked 16 health insurers for documentation on patients who have been denied coverage of drugs used to cure hepatitis C, a person familiar with the matter told Reuters on Wednesday.Schneiderman's office also requested details on procedures followed by the companies to authorize the drugs used to treat hepatitis C, the person said.The Attorney General's office has issued subpoenas to health insur

Are States Obligated to Provide Expensive Hepatitis C Drugs?

A handful of federal lawsuits against states that have denied highly effective but costly hepatitis C drugs to Medicaid patients and prisoners could cost states hundreds of millions of dollars.The drugs boast cure rates of 95 percent or better, compared to 40 percent for previous treatments. But they cost between $83,000 and $95,000 for a single course of treatment.The class actions, all filed in the last eight months in federal courts in Indiana, Massachu

Why is Gilead charging VA $40,000 for drug?

Editor's Note: U.S. Rep. Jeff Miller, R-Florida, is the chairman of the House Committee on Veterans' Affairs. The opinions expressed in this commentary are solely those of the author. (CNN) In America, honoring our veterans comes second nature to most citizens. That's because the overwhelming majority of our people understand that, if not for the service and sacrifice of those who have worn the uniform, the United States would not be the extraordinary plac

US Prisoners get sofosbuvir-simeprevir with new Guidelines

In Canada, we are still awaiting the kind of hepatitis C treatment now recommended for federal prisoners in the USA! New guidelines were just released in May 2014 and are available here: http://www.bop.gov/resources/pdfs/hepatitis_c_current.pdf These are the recommended treatments for federal prisoners with chronic hepatitis C, according to genotype (GT): GT1: PREVIOUS NON-RESPONDER (partial or null) TO INTERFERON TREATMENT or INTERFERON-INTOLERANTcombine